Class information for:
Level 1: PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY//JC VIRUS//PROGRESSIVE MULTIFOCAL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
3993 1792 35.7 79%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1199 8822 MERKEL CELL CARCINOMA//JC VIRUS//BK VIRUS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY Author keyword 508 75% 20% 362
2 JC VIRUS Author keyword 447 75% 18% 326
3 PROGRESSIVE MULTIFOCAL Author keyword 76 93% 2% 28
4 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY PML Author keyword 64 88% 2% 30
5 NATALIZUMAB Author keyword 60 32% 9% 155
6 JCV Author keyword 56 55% 4% 70
7 NEUROTOXICOL SECT Address 37 81% 1% 22
8 MOL MED NEUROSCI Address 27 41% 3% 52
9 JC POLYOMAVIRUS Author keyword 25 73% 1% 19
10 PML Author keyword 24 19% 6% 113

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 508 75% 20% 362 Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY
2 JC VIRUS 447 75% 18% 326 Search JC+VIRUS Search JC+VIRUS
3 PROGRESSIVE MULTIFOCAL 76 93% 2% 28 Search PROGRESSIVE+MULTIFOCAL Search PROGRESSIVE+MULTIFOCAL
4 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY PML 64 88% 2% 30 Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY+PML Search PROGRESSIVE+MULTIFOCAL+LEUKOENCEPHALOPATHY+PML
5 NATALIZUMAB 60 32% 9% 155 Search NATALIZUMAB Search NATALIZUMAB
6 JCV 56 55% 4% 70 Search JCV Search JCV
7 JC POLYOMAVIRUS 25 73% 1% 19 Search JC+POLYOMAVIRUS Search JC+POLYOMAVIRUS
8 PML 24 19% 6% 113 Search PML Search PML
9 AGNOPROTEIN 19 70% 1% 16 Search AGNOPROTEIN Search AGNOPROTEIN
10 JC VIRUS JCV 18 89% 0% 8 Search JC+VIRUS+JCV Search JC+VIRUS+JCV

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 231 30% 36% 645
2 HUMAN POLYOMAVIRUS JC 186 83% 6% 104
3 HUMAN NEUROTROPIC POLYOMAVIRUS 102 88% 3% 49
4 JC VIRUS DNA 91 62% 5% 94
5 HUMAN PAPOVAVIRUS JC 72 100% 1% 23
6 HUMAN POLYOMAVIRUS 70 55% 5% 87
7 HUMAN NEUROTROPIC VIRUS 50 84% 2% 27
8 JC VIRUS 50 24% 10% 179
9 BK VIRUS 44 27% 8% 142
10 FETAL GLIAL CELLS 33 74% 1% 25

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases 2010 278 23 83%
PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section 2013 50 52 81%
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis 2010 185 101 89%
Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies 2010 171 41 88%
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab 2012 83 29 66%
Progressive multifocal leukoencephalopathy in rheumatic diseases - Evolving clinical and pathologic patterns of disease 2007 88 78 85%
Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter 2013 20 143 87%
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring 2011 95 58 66%
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring 2007 103 63 70%
Monoclonal anti body-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project 2009 188 51 67%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NEUROTOXICOL SECT 37 81% 1.2% 22
2 MOL MED NEUROSCI 27 41% 2.9% 52
3 NEUROVIROL CANC BIOL 18 31% 2.7% 48
4 NEUROVIROL 10 14% 3.7% 66
5 MOL NEUROVIROL 9 52% 0.7% 12
6 VIRAL INFECTMINATO KU 8 75% 0.3% 6
7 NEUROVIROL NEUROL 6 100% 0.2% 4
8 CENT CYTOPATHOL 4 75% 0.2% 3
9 VIROL VACCINE MED 4 75% 0.2% 3
10 MULTIPLE SCLEROSIS CLIN DEV GRP 3 100% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000230665 BK VIRUS//HEMORRHAGIC CYSTITIS//POLYOMAVIRUS BK
2 0.0000207994 SV40//SIMIAN VIRUS 40//AERODIGEST PROGRAM
3 0.0000108107 POLYOMAVIRUS VP1//SV40 VECTORS//SECT VIROL ONCOL
4 0.0000088502 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME//IMMUNE RESTORATION DISEASE//IMMUNE RECONSTITUTION SYNDROME
5 0.0000079846 PUR ALPHA//TEF 1//RTEF 1
6 0.0000064463 VACUOLAR MYELOPATHY//AIDS DEMENTIA COMPLEX//CEREBRAL TOXOPLASMOSIS
7 0.0000063764 BIOCHEM A703//MIDDLE T ANTIGEN//MIDDLE T
8 0.0000063520 GLATIRAMER ACETATE//INTERFERON BETA//INTERFERON BETA 1B
9 0.0000059147 FLUORESCENT FOCUS ASSAY//FUYOU BRANCH//GLOBAL NEUROL PROGRAM
10 0.0000043896 MERKEL CELL CARCINOMA//MERKEL CELL POLYOMAVIRUS//MCPYV